Activation of intracellular enzyme systems under the influence of pathogenetic factors of oncogenesis in patients with type 2 diabetes mellitus
Journal Title: Міжнародний ендокринологічний журнал - Year 2019, Vol 15, Issue 3
Abstract
Background. It is proved that patients with diabetes mellitus (DM) have an increased risk of cancer. The main factors of oncogenesis in DM are obesity, cytokine imbalance, hyperinsulinemia (HI), hyperglycemia. These disorders cause dysfunction of the intracellular regulatory signaling pathways, the main of which is PI3K/Akt/mTOR. The purpose of the work was to study the role of phosphorylated Akt-protein kinase (phospho-Akt) in the oncogenesis processes in patients with type 2 DM. Materials and methods. Seventy-five people were examined. Patients were divided into groups: І — healthy, ІІ — persons with DM type 2, ІІІ — patients with cancer, IV — patients with cancer and DM type 2. Patients with breast, endometrial, pancreatic and intestinal cancer were included in the study. The levels of insulin, insulin-like growth factor 1 (IGF-1) and phospho-Akt were determined. Results. Patients of groups II and IV had a decompensated DM with HbA1c level > 8.0 %. Reliable HI was found in patients with DM in groups II and IV (p < 0.05), IGF-1 level was increased in all study groups (p < 0.05). Levels of phospho-Akt in patients from groups II and III were elevated (p < 0.05) and in group IV — reduced (p < 0.05). In the third group, HI in patients with breast, endometrial and intestinal cancer (p < 0.05) was detected, as well as elevation of IGF-1 regardless of localization (p < 0.05). In group IV, increased content of insulin and IGF-1 were detected in patients with breast and endometrial cancer (p < 0.05). In women from group III with breast and endometrial cancer, the level of IGF-1 was higher than that of group IV (p < 0.05). In patients treated with metformin monotherapy, phospho-Akt level was significantly lower (p < 0.05). There was a direct correlation between phospho-Akt and IGF-1 in patients of group II (r = 0.50; p < 0.05) and between phospho-Akt and insulin in group III (r = 0.45; p < 0.05). Conclusions. HI and IGF-1 are common pathogenetic factors of type 2 DM and cancer. The elevated level of phospho-Akt can serve as a laboratory indicator of cancer risk in healthy individuals. The combination of type 2 DM and cancer causes a decrease in phospho-Akt due to the competitive interaction of intracellular signaling pathways. Metformin therapy helps to reduce phospho-Akt level and can be considered as one of the ways to prevent cancer.
Authors and Affiliations
T. S. Vatseba
Keywords
Related Articles
- EP ID EP605828
- DOI 10.22141/2224-0721.15.3.2019.172107
- Views 35
- Downloads 0
Thyrotoxicosis Syndrome
No abstract
Pioglitazone: Thoughts about Reality and Prospects for Use
No abstract
Immune and anti-inflammatory factors in the mechanism of therapeutic effect of metformin in type 2 diabetes mellitus (analytical review including the results of own researches)
The review deals with the analysis of modern literature, including the results of own researches on the mechanism of the therapeutic effect of metformin in patients with type 2 diabetes mellitus (DM2) and its complicat...
Antiendotoxin Immunity and C-Reactive Protein Level in Patients with Diffuse Toxic Goiter and Heart Pathology
The changes in cardiovascular system take one of the leading places in the clinic of diffuse toxic goiter (DTG) and can define prognosis for a disease. Endotoxin (ET) can be the inductor of a systemic inflammation in pat...
Vitamin-mineral premix and treatment of diffusive nontoxic goiter
Background. The content of microelements and vitamins was studied in adolescents with diffuse nontoxic goiter (DNG). The purpose of the study is to substantiate the use of vitamin-mineral premixes in the treatment of ado...